Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04400539
Title The IMmunotherapy Pleural 5-ALA PDT (IMPALA)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Lille
Indications

malignant pleural mesothelioma

Therapies

Nivolumab

Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.